Federal Register Notice: FDA has determined that Periactin (cyproheptadine HCl) 4 mg tablets were not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve abbreviated new drug applications for cyproheptadine HCl 4 mg tablets. To view this notice, click here.
